Inflammation Signature May Predict Checkpoint Inhibitor Response in Gastroesophageal Cancer, Study Finds
Labcorp and OmniSeq Launch Insight, Next-Generation Sequencing Platform to Advance Precision Oncology
OmniSeq Receives New York State Approval for Cancer Genomic, Immune Profiling Test
Cancer-testis antigen detection by targeted RNA sequencing
Abstract Background: Cancer-testis antigens (CTAs) have restricted expression in normal adult tissues but have been found to be overexpressed in multiple tumors. This and their ability to elicit spontaneous cellular and humoral immune responses have rendered CTAs as...Cancer testis antigen co-expression landscape in solid tumors
Abstract Background Cancer testis antigens (CTAs) are tumor antigens that have a highly tissue-restricted expression but are often expressed in diverse malignancies. With their highly immunogenic expression limited to tumor cells, CTAs have become a prime target for...
Follow Us on Twitter
Twitter feed is not available at the moment.